Press Release Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference 14 hours ago
Press Release Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile Aug 4